Cleared Traditional

K924703 - LACTATE DEHYDROGENASE (LD) TEST ITEM #65418

K924703 is an FDA 510(k) clearance for LACTATE DEHYDROGENASE (LD) TEST ITEM #65418, manufactured by Em Diagnostic Systems, Inc.. The device is a Class 2 Chemistry device with product code CFJ cleared through the Traditional 510(k) pathway after a 141-day FDA review.

K924703 · Em Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1993
Decision
141d
Days
Class 2
Risk

K924703 is an FDA 510(k) clearance for the LACTATE DEHYDROGENASE (LD) TEST ITEM #65418. Classified as Nad Reduction/nadh Oxidation, Lactate Dehydrogenase (product code CFJ), Class II - Special Controls.

Submitted by Em Diagnostic Systems, Inc. (Gibbstown, US). The FDA issued a Cleared decision on February 5, 1993 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Em Diagnostic Systems, Inc. devices

FDA 510(k) Submission Details - K924703

510(k) Number K924703 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 1992
Decision Date February 05, 1993
Days to Decision 141 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 88d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFJ Device Classification - Class 2, Special Controls

Product Code CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

All 104
Devices cleared under the same product code (CFJ) and FDA review panel - the closest regulatory comparables to K924703.
HICHEM LDH/L REAGENT KIT
K946022 · Hichem Diagnostics · Feb 1995
LACTATE DEHYDROGENASE QVET
K942964 · Prisma Systems · Dec 1994
LACTATE DEHYDROGENASE (LD)
K935175 · Em Diagnostic Systems, Inc. · Dec 1993
OLYMPUS LACTATE DEHYDROGENASE REAGENT
K924965 · Olympus Corp. · Nov 1992
OLYMPUS LACTATE DEHYDROGENASE REAGENT
K923412 · Olympus Corp. · Sep 1992
SYNERMED LDHH-L REAGENT KIT
K921025 · Synermed, Inc. · Mar 1992